A survey on the management of acute rhinosinusitis among Asian physicians

Rhinology

Volumn 49, Issue 3, 2011, Pages 264-271

  Wang, De Yun ^a   Wardani, Retno S ^b   Singh, Kuljit ^c   Thanaviratananich, Sanguansak ^d   Vicente, Gil ^e   Xu, Geng ^f   Zia, Mohammed Rashid ^g   Gulati, Achal ^h   Fang, Sheen Yie ⁱ   Shi, Li ^j   Chan, Yiong Huak ^a   Price, David ^k   Lund, Valerie J ^l   Mullol, Joaquim ^m   Fokkens, Wytske J ⁿ  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b CIPTO MANGUNKUSUMO HOSPITAL   (Indonesia)

^c Princecourt Medical Centre   (Malaysia)

^d KHON KAEN UNIVERSITY   (Thailand)

^e St Luke's Medical Centre   (Philippines)

^f THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^g JINNAH HOSPITAL   (Pakistan)

^h MAULANA AZAD MEDICAL COLLEGE   (India)

ⁱ Chiali Medical Corporation Aggregate Chiali Hospital   (Taiwan)

^j SHANDONG UNIVERSITY   (China)

^k UNIVERSITY OF ABERDEEN   (United Kingdom)

^l UNIVERSITY COLLEGE LONDON   (United Kingdom)

^m INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

ⁿ ACADEMIC MEDICAL CENTER   (Netherlands)

more..

Author keywords

Acute rhinosinusitis; Antibiotics; Asia; Diagnosis; Nasal corticosteroids; Treatment

Indexed keywords

ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT;

ACUTE DISEASE; ARTICLE; DRUG UTILIZATION; HEALTH CARE SURVEY; HUMAN; RHINITIS; SINUSITIS; SOUTHEAST ASIA;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; ASIA, SOUTHEASTERN; DRUG UTILIZATION; HEALTH CARE SURVEYS; HISTAMINE ANTAGONISTS; HUMANS; RHINITIS; SINUSITIS;

EID: 80051748569     PISSN: 03000729     EISSN: None     Source Type: Journal    
DOI: 10.4193/rhino10.169     Document Type: Article

References (19)

1. Fokkens W, Lund V, Mullol J. European position paper on rhinosinusitis and nasal polyps 2007. Rhinology 2007. Suppl. 20: 1-136.
2. Giesbers HrNo-IVTV, Nationale Atlas Volksgezondheid. Bilthoven: RIVM, Gezondheid\Ziekten en aandoeningen\ Ziekten van de ademhalingswegen, 27 september 2002. Neusbijholte ontsteking 1995-1999. 2002 cited; Available from: http://www.zorgatlas.nl.
3. Gijsen R, Poos M. Nationaal Kompas. 2003 cited; Available from: Fokkens W, Lund V, Mullol J, on behalf of the European Position Paper on Rhinosinusitis and Nasal Polyps group. European position paper on rhinosinusitis and nasal polyps 2007. Rhinology. 2007; Supplement 20: 1-136.
4. Anon JB, Jacobs MR, Poole MD, Ambrose PG, Benninger MS, Hadley JA, et al. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg. 2004; 130(1 Suppl): 1-45.
5. Thomas M, Yawn BP, Price D, Lund V, Mullol J, Fokkens W. EPOS Primary Care Guidelines: European Position Paper on the Primary Care Diagnosis and Management of Rhinosinusitis and Nasal Polyps 2007 - a summary. Prim Care Respir J. 2008; 17: 79-89.
6. Hickner JM, Bartlett JG, Besser RE, Gonzales R, Hoffman JR, Sande MA. Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Intern Med. 2001; 134: 498-505.
7. Cars O, Mõlstad S, Melander A. Variation in antibiotic use in the European Union. Lancet. 2001; 357: 1851-1853.
8. Wise R, Hart T, Cars O. Streulens M, Helmuth R, Huovinen P, et al. Antimicrobial resistance. Is a major threat to public health. BMJ. 1998; 317: 609-610.
9. Felmingham D, Reinert RR, Hirakata Y, Rodloff A. Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and compatative in vitro activity of the ketolide, telithromycin. J Antimicrob Chemother. 2002; 50 Suppl S1: 25-37.
10. Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005; 365: 579-587.
11. Williams JW Jr, Aguilar C, Cornell J, Chiquette E, Dolor RJ, Makela M, Holleman DR, et al. Antibiotics for acute maxillary sinusitis. Cochrane Database Syst Rev. 2003: CD000243.
12. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its Impact on Asthma. J Allergy Clin Immunol. 2001; 108 (5 Suppl): S147-334.
13. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic rhinitis and its Impact on Asthma (ARIA) 2008 Update. Allergy. 2008; 63 (Suppl 86): 1-160.
14. Mullol J, Obando A, Pujols L, Alobid I. Corticosteroid treatment in chronic rhinosinusitis: the possibilities and the limits. Immunol Allergy Clin North Am. 2009; 29: 657-668.
15. Li CW, Cheung W, Lin ZB, Li TY, Lim JT, Wang DY. Oral steroids enhance epithelial repair in nasal polyposis via up-regulation of AP-1 gene network. Thorax. 2009; 64; 306-312.
16. Zalmanovici A, Yaphe J. Intranasal steroids for acute sinusitis. Cochrane Database Syst Rev. 2009: CD005149.
17. Meltzer EO, Bachert C, Staudinger H. Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. J Allergy Clin Immunol. 2005; 116: 1289-1295.
18. Bachert C, Meltzer EO. Effect of mometasone furoate nasal spray on quality of life of patients with acute rhinosinusitis. Rhinology. 2007; 45: 190-196.
19. Williamson IG, Rumsby K, Benge S, Moore M, Smith PW, Cross M, et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA. 2007; 298: 2487-2496.